Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mert Karaoğlan"'
Autor:
Mert Karaoğlan, Gizem Kumru, Rezzan Eren Sadioğlu, Merve Aktar, Şayeste Akkan Eren, Saba Kiremitçi, Sim Kutlay, Şehsuvar Ertürk, Kenan Keven, Şule Şengül
Publikováno v:
Turkish Journal of Nephrology, Vol 33, Iss 1, Pp 91-101 (2024)
Externí odkaz:
https://doaj.org/article/d1ddcd9a6f53461e927a853e33f6b071
Autor:
Fidan Erden Karaoğlan, Mert KARAOĞLAN
Publikováno v:
Applied Microbiology and Biotechnology. 106:7073-7083
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd62dde821627dec8a3c22ef6cda6543
https://doi.org/10.1007/s00253-022-12183-8
https://doi.org/10.1007/s00253-022-12183-8
Autor:
Mustafa GÜRBÜZ, İzzet DOĞAN, Erman AKKUŞ, İbrahim KARADAĞ, Serdar KARAKAYA, Cihan EROL, Ramazan ACAR, Mert KARAOĞLAN, Elif Berna KÖKSOY, Berna SAVAŞ, Mehmet Ali Nahit ŞENDUR, Didem TAŞTEKİN, Nuri KARADURMUŞ, Ömür Berna ÇAKMAK ÖKSÜZOĞLU, Filiz ÇAY ŞENLER
Publikováno v:
Journal of Oncological Sciences. 8:14-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3cdb0da2552ee4ac1fd82ea49f47949
https://doi.org/10.37047/jos.2021-86554
https://doi.org/10.37047/jos.2021-86554
Autor:
Mert Karaoğlan
Publikováno v:
Enzyme and Microbial Technology. 168:110256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd76e5e9b18aaa63985280ee1cd02f3
https://doi.org/10.1016/j.enzmictec.2023.110256
https://doi.org/10.1016/j.enzmictec.2023.110256
Publikováno v:
Biotechnology journalREFERENCES. 17(2)
Pichia pastoris (Komagataella phaffii) is a non-conventional Crabtree-negative yeast with the capability of reaching very high cell densities in a fed-batch fermentation process. The alcohol dehydrogenase (ADH) genes of P. pastoris involved in ethano
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31823f28144d88461c0629a9f062e963
https://pubmed.ncbi.nlm.nih.gov/34870891
https://pubmed.ncbi.nlm.nih.gov/34870891
Autor:
Mustafa Altinbaş, Mustafa Gürbüz, Saadettin Kilickap, Necdet Uskent, Mert Karaoğlan, Nazim Serdar Turhal, Deniz Can Guven, Atakan Demir, Dogan Uncu, Teoman Sakalar, Cihan Erol, Suleyman Sahin, Semiha Urvay, Ahmet Z. Sahin, Sema Türker, Nuri Karadurmus, Abdullah Sakin, Atike Gökçen Demiray, Havva Yesil Cinkir, Mehmet Ali Nahit Sendur, Yakup Ergun, Filiz Çay Şenler, Erdem Cubukcu, Ramazan Acar, Erman Akkus
Purpose: Taxane-containing combinations are recommended for the first-line therapy of advanced gastric cancer. It is not known which chemotherapy regimen is the best with trastuzumab for HER2-positive patients. The aim of this study was to compare ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::826e70952ae73e6e6c2a95be74f99e71
https://avesis.yyu.edu.tr/publication/details/ed684080-b556-42b5-8d19-e519ca6102e0/oai
https://avesis.yyu.edu.tr/publication/details/ed684080-b556-42b5-8d19-e519ca6102e0/oai
Autor:
Mustafa Altinbaş, Erdem Cubukcu, Atakan Demir, Mustafa Gürbüz, Cihan Erol, Ramazan Acar, Saadettin Kilickap, Filiz Çay Şenler, Semiha Urvay, Dogan Uncu, Mert Karaoğlan, Yakup Ergun, Ahmet Z. Sahin, Sema Türker, Nazim Serdar Turhal, Nuri Karadurmus, Havva Yesil Cinkir, Suleyman Sahin, Deniz Can Guven, Necdet Uskent, Teoman Sakalar, Abdullah Sakin, Atike Gökçen Demiray, Mehmet Ali Nahit Sendur, Erman Akkus
Purpose: In the ToGA trial for HER2-positive advanced gastric cancer, cisplatin plus fluoropyrimidine was given for 6 cycles; trastuzumab was given until disease progression. However, there is a lack of real-life data about trastuzumab maintenance af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140c60163f8e315841ad27de17b812e2
https://avesis.yyu.edu.tr/publication/details/c4aa590e-e6e7-4cb9-920b-f862618eae15/oai
https://avesis.yyu.edu.tr/publication/details/c4aa590e-e6e7-4cb9-920b-f862618eae15/oai